Subscribe
Israel-Hamas Conflict
US Politics
Hurricanes
Republican Party
Donald Trump
US Presidential Election
Election Day
Fox News
US Economy
Kamala Harris
US Crime
Halloween
NFL
Published

Global Health Developments: New Approvals, Outages, and Outbreaks

Summary by Devdiscourse
Global Health Developments: New Approvals, Outages, and Outbreaks In recent health news, Eli Lilly announced that China's regulators have approved its weight loss drug, tirzepatide. This approval intensifies Eli Lilly's competition with Novo Nordisk in the Asian market. The announcement saw a 1.6% rise in the company's shares, trading at $862.39.Two German hospitals in Luebeck and Kiel canceled elective operations due to a global IT outage link…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Eli LillyEli Lilly
ChinaChina

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal